Scientists report that the lipid-based nanoparticles they engineered, carrying two sets of protein-making instructions, showed in animal studies that they have the potential to function as therapies for two genetic disorders.
Friday, August 21, 2020
Nanomaterials show promise for treating hemophilia and cardiovascular disorder
Scientists report that the lipid-based nanoparticles they engineered, carrying two sets of protein-making instructions, showed in animal studies that they have the potential to function as therapies for two genetic disorders.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment